Rigel Pharmaceuticals Inc 10-K for FY2024
Rigel Pharmaceuticals Inc (RIGL)
10-K
2025-03-04
For: 2024-12-31
View Original
Added on
April 06, 2026
About this 10-K
Rigel Pharmaceuticals Inc filed this 10-K on March 4, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $179.28M
- up 53.4% from $116.88M a year earlier
- Net income
- $17.49M
- compared with a net loss of $25.09M a year earlier
- Diluted EPS
- $0.99
- compared with -$1.44 a year earlier